Dipraglurant

未知生产厂商

Dipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Dipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).

技术标识符

化学式: C₁₆H₁₂FN₃
CAS 编号: 872363-17-2
UNII ID: CV8JZR21A1

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor
申请人: ADDEX PHARMACEUTICALS SA优先权: 2013
US

药物